Lu Li
Stock Analyst at UBS
(2.46)
# 2,984
Out of 5,036 analysts
30
Total ratings
58.3%
Success rate
5.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Maintained: Hold | n/a | $15.97 | - | 1 | Oct 8, 2026 | |
| DHR Danaher | Initiated: Buy | $250 | $204.85 | +22.04% | 2 | Sep 10, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $52 → $65 | $43.86 | +48.20% | 7 | Sep 9, 2026 | |
| WAT Waters | Upgraded: Buy | $375 → $490 | $404.81 | +21.04% | 3 | Sep 9, 2026 | |
| QDEL QuidelOrtho | Rated: Hold | $17 → $12 | $12.64 | -5.06% | 7 | May 7, 2026 | |
| FLGT Fulgent Genetics | Reiterated: Buy | $35 → $22 | $19.85 | +10.83% | 3 | Mar 2, 2026 | |
| MYGN Myriad Genetics | Reiterated: Hold | $8 → $6 | $3.19 | +88.09% | 7 | Feb 25, 2026 |
NeoGenomics
Oct 8, 2026
Maintained: Hold
Price Target: n/a
Current: $15.97
Upside: -
Danaher
Sep 10, 2026
Initiated: Buy
Price Target: $250
Current: $204.85
Upside: +22.04%
Veracyte
Sep 9, 2026
Reiterated: Buy
Price Target: $52 → $65
Current: $43.86
Upside: +48.20%
Waters
Sep 9, 2026
Upgraded: Buy
Price Target: $375 → $490
Current: $404.81
Upside: +21.04%
QuidelOrtho
May 7, 2026
Rated: Hold
Price Target: $17 → $12
Current: $12.64
Upside: -5.06%
Fulgent Genetics
Mar 2, 2026
Reiterated: Buy
Price Target: $35 → $22
Current: $19.85
Upside: +10.83%
Myriad Genetics
Feb 25, 2026
Reiterated: Hold
Price Target: $8 → $6
Current: $3.19
Upside: +88.09%